BIOSENSE TECHNOLOGIES, INC.

Basic Information

4 ARROW DR
WOBURN, MA, 01801-2040

Company Profile

n/a

Additional Details

Field Value
DUNS: 122648533
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 3


  1. Rapid Testing of Drug Resistant BCR-ABL(+) Leukemia Cells

    Amount: $1,020,897.00

    DESCRIPTION (provided by applicant): Resistance to chemotherapeutic drugs is an ongoing problem that results in eventual treatment failures or suboptimal patient outcomes. Approximately one-quarter of ...

    SBIR Phase II 2013 Department of Health and Human Services
  2. Rapid Testing of Drug-Resistant BCR-ABL(+)Leukemia Cells

    Amount: $199,691.00

    DESCRIPTION (provided by applicant): Resistance to chemotherapeutic drugs is an ongoing problem that results in eventual treatment failures or suboptimal patient outcomes. In cancer cells treated with ...

    SBIR Phase I 2011 Department of Health and Human Services
  3. Diagnosis of Extra-Pulmonary Tuberculosis in HIV Patients

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The diagnosis of tuberculosis (TB) in individuals co-infected with human immunodeficiency virus is significantly challenged by the increased prevalence of extra-p ...

    SBIR Phase I 2008 Department of Health and Human Services
  4. SBIR Phase II: Early Growth Metabolic Responses of Mycobacteria

    Amount: $429,080.00

    This SBIR Phase II research project develops a new rapid, nonmolecular method for quickly testing the drug susceptibility of Mycobacteria tuberculosis, the bacterium causing the epidemic disease tuber ...

    SBIR Phase II 2008 National Science Foundation
  5. Rapid Diagnostic Testing of Urinary Tract Infections

    Amount: $750,000.00

    DESCRIPTION (provided by applicant): Abstract The continued development of a rapid diagnostic method for testing the antibiotic susceptibility of urinary tract infections in near real- ...

    SBIR Phase II 2008 Department of Health and Human Services
  6. Rapid Diagnostic Testing of Urinary Tract Infections

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The development of a new rapid diagnostic method for testing the antibiotic susceptibility of urinary tract infections is proposed. The technical approach is based ...

    SBIR Phase I 2006 Department of Health and Human Services
  7. SBIR Phase I: Early Growth Metabolic Responses of Mycobacteria

    Amount: $100,000.00

    This Small Business Innovation Research Phase I project describes a method for the drug susceptibility testing of mycobacteria having speed and simplicity. The technical approach is based on a novel i ...

    SBIR Phase I 2006 National Science Foundation
  8. SBIR Phase I: Rapid Antibiotic Suceptibility Testing of Sexually Transmitted Infections

    Amount: $100,000.00

    This Small Business Innovation Research (SBIR) Phase I project proposes the development of a new test to diagnose pathogenic microorganisms causing sexually transmitted infections at the point-of-care ...

    SBIR Phase I 2006 National Science Foundation
  9. Rapid Detection of Bacterial Contamination in Platelets

    Amount: $48,595.00

    DESCRIPTION (provided by applicant): The development of a rapid and simple method for the diagnostic testing of pathogenic bacteria in platelet products is proposed. The technical approach is based on ...

    SBIR Phase I 2005 Department of Health and Human Services
  10. Rapid Antibiotic Susceptibility Testing

    Amount: $476,168.00

    DESCRIPTION (provided by applicant): The development of a new method for the diagnostic testing of Mycobacterium tuberculosis having unparalleled speed and simplicity is proposed. The technical appro ...

    SBIR Phase I 2003 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government